Basic Research in Cardiology

, Volume 83, Issue 4, pp 376–383 | Cite as

Opioids stimulate sarcolemmal NAD(P)H-vanadate dehydrogenase activity

  • C. Ventura
  • C. Guarnieri
  • L. Bastagli
  • C. M. Caldarera
Original Contributions


The present study demonstrates that the bovine cardiac sarcolemma possesses an NAD(P)H dehydrogenase activity which is able to oxidize both NADH and NAD(P)H in the presence of vanadate as an electron acceptor.

The NADH dehydrogenase activity was significantly higher than the NAD(P)H dehydrogenase activity and both of them were almost completely inhibited by superoxide dismutase and atebrin and markedly reduced by the addition of the protonophore 2,4-dinitrophenol. The incubation of the sarcolemma in the presence of 10−10, 10−9, 10−8 M methionine-enkephalin, a prevalent δ-opioid receptor agonist, or dynorphin A (1–17), a prevalent κ-receptor agonist, produced a dose-dependent increase in the NAD(P)H dehydrogenase activity, with 10−10 and 10−9 M dynorphin A (1–17) more effective than the corresponding doses of methionine-enkephalin. The preincubation of the sarcolemma in the presence of superoxide-dismutase, atebrin or 2,4-dinitrophenol strongly inhibited the opioid-stimulated dehydrogenase activity.

The stimulatory action elicited by 10−8 M methionine-enkephalin or dynorphin A (1–17) was completely antagonized by 10−8 M naloxone or Mr 1452, respectively, whilst 10−8 M naloxone exerted only a partially antagonistic action against the effect produced by 10−8 M dynorphin A (1–17), significantly more accentuated than the action of 10−8 M Mr 1452 versus the same dose of methionine-enkephalin.

Key words

isolated cardiacsarcolemma NAD(P)H-vanadate dehydrogenase activity opioid peptides 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Aronson NN, Touster O (1974) Isolation of rat liver plasma membrane fragments in isotonic sucrose. In: Fleischer S, Packer L (eds) Method Enzymol. Vol 31, Academic Press, New York, pp 90–102Google Scholar
  2. 2.
    Bowen WD, Hellewell SB, Kelemen M, Huey R, Stewart D (1987) Affinity labeling of δ-opiate receptors using (D-Ala2, Leu5, Cys6) Enkephalin. J Biol Chem 262:13434–13439PubMedGoogle Scholar
  3. 3.
    Brain RD, Freeberg JA, Weiss CV, Briggs WR (1977) Blue-light induced absorbance changes in membrane fractions from corn and neurospora. Plant Physiol 59:948–952Google Scholar
  4. 4.
    Clô C, Muscari C, Tantini B, Pignatti C, Bernardi P, Ventura C (1985) Reduced mechanical activity of perfused rat heart following morphine or enkephalin peptides administration. Life Sci 37:1327–1333CrossRefPubMedGoogle Scholar
  5. 5.
    Colbeau A, Nachbaur J, Vignais PM (1971) Enzymic characterization and lipid composition of rat liver subcellular membranes. Biochim Biophys Acta 249:462–492PubMedGoogle Scholar
  6. 6.
    Crane FL, Low H (1976) NADH oxidation in liver and fat cell plasma membranes. FEBS Lett 68:153–156CrossRefPubMedGoogle Scholar
  7. 7.
    Crane FL, Goldenberg H, Morrè DJ, Low H (1979) Dehydrogenases of the plasma membranes. In: Roodyn DB (ed) Subcellular Biochemistry Vol 6, Plenum Press, New York, pp 345–399Google Scholar
  8. 8.
    Dhalla NS, McNamara DB, Anand MB (1976) Heart sarcolemma as a dynamic exictable membrane. In: Roy PE, Dhalla NS (eds) Recent advances in Studies on Cardiac Structure and Metabolism, The Sarcolemma, Vol 9, University Park Press, Baltimore, pp 1–19Google Scholar
  9. 9.
    Dhalla NS, Smith CI, Pierce GN, Elimban V, Makino N, Khatter JC (1986) Heart sarcolemma cation pumps and binding sites. In: Rupp H (ed) The regulation of heart function. Thieme Inc, New York, pp 121–136Google Scholar
  10. 10.
    Eldan M, Mayer AM (1972) Evidence for the activation of NADH-Cytochrome c reductase during germination of lettuce. Plant Physiol 26:67–72Google Scholar
  11. 11.
    Erdmann E, Krawietz W, Phillip G, Hackbarth I, Schmitz W, Scholz H, Crane FL (1979) Purified cardiac cell membranes with high Na+−K+ ATPase activity contain significant NADH-vanadate reductase activity. Nature 282:335–336CrossRefPubMedGoogle Scholar
  12. 12.
    Erdmann E, Werdan K, Krawietz W, Lebuhn M, Christl S (1980) Significance of NADH-vanadateoxidoreductase of cardiac and erythrocyte cell membranes. Basic Res Cardiol 75:460–465CrossRefPubMedGoogle Scholar
  13. 13.
    Gayda DP, Crane FL, Morrè DJ, Low H (1977) Hormone effects on NADH oxidizing enzymes of plasma membranes of rat liver. Proc Indiana Acad Sci 86:385–390Google Scholar
  14. 14.
    Gould JM, Cramer WA (1977) Relationship between oxygen-induced proton efflux and membrane energization in cells of escherichia coli. J Biol Chem 252:5875–5882PubMedGoogle Scholar
  15. 15.
    Guarnieri C, Ventura C, Georgountzos A, Muscari C, Budini R (1985) Involvement of superoxide radicals on adrenochrome formation stimulated by arachidonic acid in bovine heart sarcolemmal vescicles. Biochim Biophys Acta 838:355–360PubMedGoogle Scholar
  16. 16.
    Hughes J (1981) Peripheral opiate receptor mechanism. Trends in Pharmacol Sci 2:21–24CrossRefGoogle Scholar
  17. 17.
    Ichikawa Y, Mason HS (1977) Distribution of cytochrome P-450 and related redox systems among hepatocyte membranes. In: King TE (ed) Oxidases and Related Redox Systems, Proceedings of the Second International Symposium, Vol 2, University Park Press, Baltimore, pp 605–625Google Scholar
  18. 18.
    Kuhl PW (1985) A redox cyclic model for the action of β-adrenoceptor agonists. Experientia 41:1118–1222CrossRefPubMedGoogle Scholar
  19. 19.
    Lamers JMJ, Stinis JT (1981) An electrogenic Na+/Ca2+ antiporter in addition to the Ca2+ pump in cardiac sarcolemma. Biochim Biophys Acta 640:521–534PubMedGoogle Scholar
  20. 20.
    Liochev S, Fridovich I (1986) The vanadate-stimulated oxidation of NAD(P)H by biomembranes is a superoxide-initiated free radical reaction. Arch Biochem Biophys 250:139–145CrossRefPubMedGoogle Scholar
  21. 21.
    Lord JAH, Waterfield AA, Hughes J, Kosterlitz HW (1977) Endogenous opioid peptides: multiple agonists and receptors. Nature 267:495–499CrossRefPubMedGoogle Scholar
  22. 22.
    Low H, Crane FL (1976) Hormone regulated redox function in plasma membranes. FEBS Lett 68:157–159CrossRefPubMedGoogle Scholar
  23. 23.
    Low H, Crane FL, Patrick EJ, Patten GS, Clark MG (1984) Properties and regulation of a transplasma membrane redox system of perfused rat heart. Biochim Biophys Acta 804:253–260CrossRefPubMedGoogle Scholar
  24. 24.
    Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin reagent. J Biol Chem 193:265–275PubMedGoogle Scholar
  25. 25.
    Marzullo G, Hine B (1960) Opiate receptor function may be modulated through an oxidation-reduction mechanism. Science 208:1171–1173Google Scholar
  26. 26.
    Mukerjee SP, Lynn WS (1977) Reduced nicotinamide adenine dinucleotide phosphate oxidase in adipocyte plasma membrane and its activation by insulin. Arch Biochem Biophys 184:69–76CrossRefPubMedGoogle Scholar
  27. 27.
    Ostroy SE (1977) Rhodopsin and the visual process. Biochim Biophys Acta 463:91–125PubMedGoogle Scholar
  28. 28.
    Parrat JR (1986) Opioid receptors in the cardiovascular system. In: Verlag F (ed) Progress in Pharmacology, Vol 6, New York, pp 97–110Google Scholar
  29. 29.
    Paterson SJ, Robson LE, Kosterlitz HW (1983) Classification of opioid receptors. Br Med Bull 39:31–36PubMedGoogle Scholar
  30. 30.
    Prior TI, Patel V, Drummond GI (1985) Inactivation of the β-adrenergic receptor in cardiac muscle by dithiols. Can J Physiol Pharmacol 63:932–936PubMedGoogle Scholar
  31. 31.
    Reeves JP, Sutko JL (1980) Sodium-calcium exchange activity generates a current in cardiac membrane vesicles. Science 208:1461–1464PubMedGoogle Scholar
  32. 32.
    Sawynok J, Pinsky C, La Bella FS (1979) Minireview on the specificity of naloxone as an opiate antagonist. Life Sci 25:1621–1632CrossRefPubMedGoogle Scholar
  33. 33.
    Smith JR, Simon EJ (1980) Selective protection of stereospecific enkephalin and opiate binding agonist inactivation by N-ethylmaleimide: evidence for two classes of opiate receptors. Proc Natl Acad Sci 77:281–284PubMedGoogle Scholar
  34. 34.
    Sottocasa GL, Kuylenstierna B, Ernester L, Bergstrand A (1967) An electron transport system associated with the outer membrane of liver mitochondria. J Cell Biol 32:415–437CrossRefPubMedGoogle Scholar
  35. 35.
    Strauss WL, Venter JC (1985) A sulfhydryl group of the canine cardiac beta-adrenergic receptor observed in the absence of hormone. Life Sci 36:1699–1706CrossRefPubMedGoogle Scholar
  36. 36.
    Ventura C, Muscari C, Spampinato S, Bernardi P, Caldarera CM (1987) Inhibitory action of opioid peptides on the ouabain-sensitive Na+−K+ and Ca2+-dependent ATPase activities in bovine cardiac sarcolemma. Peptides 8:709–713CrossRefPubMedGoogle Scholar
  37. 37.
    Vijaya S, Crane FL, Ramasarma T (1984) A vanadate-stimulated NADH oxidase in erythrocyte membrane generates hydrogen peroxide. Mol Cell Biochem 62:175–185CrossRefPubMedGoogle Scholar
  38. 38.
    Werdan K, Bauriedel G, Bozsik M, Krawietz W, Erdmann E (1980) Effects of vanadate in cultured rat heart muscle cells: vanadate transport, intracellular binding and vanadate-induced changes in beating and in active cation flux. Biochim Biophys Acta 597:364–383PubMedGoogle Scholar
  39. 39.
    Wright M, Drummond GI (1983) Inactivation of the β-adrenergic receptor in the skeletal muscle by dithiols. Biochem Pharmacol 32:509–515CrossRefPubMedGoogle Scholar

Copyright information

© Dr. Dietrich Steinkopff Verlag 1988

Authors and Affiliations

  • C. Ventura
    • 1
  • C. Guarnieri
    • 1
  • L. Bastagli
    • 1
  • C. M. Caldarera
    • 1
  1. 1.Department of Biochemistry, Center of Research on Cardiac MetabolismUniversity of BolognaBolognaItaly

Personalised recommendations